Search

Subject daily functioning -- quality of life -- sleep interference

1. Ligelizumab improves sleep interference and disease burden in patients with chronic spontaneous urticaria. Issue 2 (16th February 2022)

Authors:
Giménez‐Arnau, Ana; Maurer, Marcus; Bernstein, Jonathan; Staubach, Petra; Barbier, Nathalie; Hua, Eva; Severin, Thomas; Joubert, Yolandi; Janocha, Reinhold; Balp, Maria‐Magdalena
Journal:
Clinical and translational allergy
Issue:
Volume 12:Issue 2(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search

  • daily functioning -- quality of life -- sleep interference 1